Since these mutations result in loss of the respective protein, loss of staining for either SMARCB1 or SMARCA4 by immunohistochemistry is used as a diagnostic tool to ensure the diagnosis of an ATRT [30]. The gene discussed is SMARCA4; the disease is atypical teratoid rhabdoid tumor.